Global HER2 Antibody Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global HER2 Antibody market size was valued at US$ 15570 million in 2024 and is forecast to a readjusted size of USD 25010 million by 2031 with a CAGR of 7.1% during review period.

HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is recommended for all patients with HER2-positive breast cancer who are also receiving chemotherapy.

Monoclonal antibodies targeting HER2 (human epidermal growth factor receptor 2) are used in the treatment of HER2-positive breast cancer. Market trends include the development of next-generation HER2-targeted therapies and combination therapies to enhance treatment efficacy.

This report is a detailed and comprehensive analysis for global HER2 Antibody market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global HER2 Antibody market size and forecasts, in consumption value ($ Million), 2020-2031

Global HER2 Antibody market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global HER2 Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global HER2 Antibody market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for HER2 Antibody

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global HER2 Antibody market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Genentech Inc, Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited, Bio-Techne, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

HER2 Antibody market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Trastuzumab

Lapatinib

Ado-trastuzumab Emtansine

Pertuzumab

Everolimus

Market segment by Application

Hospital

Medical Center

Market segment by players, this report covers

Genentech Inc

Novartis AG

Pfizer

Abnova Corporation

InvivoGen

Celltrion

Biocon Limited

Bio-Techne

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe HER2 Antibody product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of HER2 Antibody, with revenue, gross margin, and global market share of HER2 Antibody from 2020 to 2025.

Chapter 3, the HER2 Antibody competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and HER2 Antibody market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of HER2 Antibody.

Chapter 13, to describe HER2 Antibody research findings and conclusion.